Pharming Group N.V.
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $94,374 | $79,094 | $92,672 | $75,062 |
Gross Profit | 85,261 | 70,771 | 80,459 | 68,030 |
EBITDA | 11,644 | -4,108 | 7,255 | |
EBIT | -6,690 | 4,504 | ||
Net Income | 4,657 | -14,719 | 2,859 | -1,034 |
Net Change In Cash | 94,374 | 79,094 | 92,672 | 75,062 |
Free Cash Flow | 12,288 | -56 | 9,195 | 9,376 |
Cash | 94,817 | 60,093 | 54,944 | 60,662 |
Basic Shares | 66,904 | 66,904 | 680,308 | 64,625 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $297,200 | $245,316 | $205,622 | $189,853 |
Gross Profit | 261,801 | 220,104 | 188,060 | 169,670 |
EBITDA | 16,315 | 9,877 | 33,533 | 48,779 |
EBIT | 245 | -6,048 | 20,345 | 29,169 |
Net Income | -10,644 | -10,548 | 13,674 | 15,996 |
Net Change In Cash | 297,200 | 245,316 | 205,622 | 189,853 |
Free Cash Flow | -2,591 | -18,766 | 20,920 | 20,168 |
Cash | 54,944 | 61,741 | 207,342 | 191,724 |
Basic Shares | 68,918 | 65,702 | 88,392 | 87,643 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.06 |
2025-03-31 | -$0.02 |
2024-12-31 | $0.005 |
2024-09-30 | -$0.01 |
